Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03682068
PHASE3

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a randomized, open-label, controlled, multi-center, global Phase III study to determine the efficacy and safety of combining durvalumab ± tremelimumab with standard of care (SoC) chemotherapy (cisplatin + gemcitabine or carboplatin + gemcitabine doublet) followed by durvalumab monotherapy versus SoC alone as first-line chemotherapy in patients with histologically or cytologically documented, unresectable, locally advanced or metastatic transitional cell carcinoma of the urothelium (including renal pelvis, ureters, urinary bladder, and urethra).

Official title: A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination With Standard of Care Chemotherapy and Durvalumab in Combination With Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients With Unresectable Locally Advanced or Metastatic Urothelial Cancer.

Key Details

Gender

All

Age Range

18 Years - 130 Years

Study Type

INTERVENTIONAL

Enrollment

1246

Start Date

2018-09-27

Completion Date

2027-06-01

Last Updated

2026-08-20

Healthy Volunteers

No

Interventions

DRUG

Durvalumab

Durvalumab IV (intravenous infusion)

DRUG

Tremelimumab

Tremelimumab IV (intravenous infusion)

DRUG

Cisplatin + Gemcitabine

Cisplatin IV (intravenous)+ Gemcitabine IV(intravenous), as standard of care.

DRUG

Carboplatin + Gemcitabine

Carboplatin IV (intravenous)+ Gemcitabine IV(intravenous), as standard of care.

Locations (222)

Research Site

Birmingham, Alabama, United States

Research Site

Bakersfield, California, United States

Research Site

Fullerton, California, United States

Research Site

Los Angeles, California, United States

Research Site

Salinas, California, United States

Research Site

Santa Barbara, California, United States

Research Site

Truckee, California, United States

Research Site

New Haven, Connecticut, United States

Research Site

Washington D.C., District of Columbia, United States

Research Site

Orlando, Florida, United States

Research Site

Chicago, Illinois, United States

Research Site

Fort Wayne, Indiana, United States

Research Site

Kansas City, Kansas, United States

Research Site

Louisville, Kentucky, United States

Research Site

New Orleans, Louisiana, United States

Research Site

Grand Rapids, Michigan, United States

Research Site

Bozeman, Montana, United States

Research Site

New Hyde Park, New York, United States

Research Site

New York, New York, United States

Research Site

New York, New York, United States

Research Site

Rochester, New York, United States

Research Site

Germantown, Tennessee, United States

Research Site

Fort Worth, Texas, United States

Research Site

Ciudad de Buenos Aires, Argentina

Research Site

Ciudad de Buenos Aires, Argentina

Research Site

Ciudad de Buenos Aires, Argentina

Research Site

Ciudad de Buenos Aires, Argentina

Research Site

Rosario, Argentina

Research Site

Box Hill, Australia

Research Site

Elizabeth Vale, Australia

Research Site

Kogarah, Australia

Research Site

Macquarie University, Australia

Research Site

Murdoch, Australia

Research Site

Orange, Australia

Research Site

South Brisbane, Australia

Research Site

St Albans, Australia

Research Site

Curitiba, Brazil

Research Site

Fortaleza, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Ribeirão Preto, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

Salvador, Brazil

Research Site

Santa Maria, Brazil

Research Site

São José do Rio Preto, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

Pleven, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Varna, Bulgaria

Research Site

Calgary, Alberta, Canada

Research Site

Edmonton, Alberta, Canada

Research Site

Vancouver, British Columbia, Canada

Research Site

Hamilton, Ontario, Canada

Research Site

Ottawa, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Changsha, China

Research Site

Chongqing, China

Research Site

Chongqing, China

Research Site

Dalian, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Jinan, China

Research Site

Nanchang, China

Research Site

Nanjing, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Shenyang, China

Research Site

Suzhou, China

Research Site

Tianjin, China

Research Site

Tianjin, China

Research Site

Ürümqi, China

Research Site

Wuhan, China

Research Site

Xi'an, China

Research Site

Brno, Czechia

Research Site

Hradec Králové, Czechia

Research Site

Olomouc, Czechia

Research Site

Ostrava, Czechia

Research Site

Prague, Czechia

Research Site

Prague, Czechia

Research Site

Prague, Czechia

Research Site

Budapest, Hungary

Research Site

Budapest, Hungary

Research Site

Budapest, Hungary

And 122 more locations on ClinicalTrials.gov